Rhabdomyosarcoma, a common form of soft tissue sarcoma in pediatric patients with outcomes that have improved through research, is rare among older patients, who also have significantly poorer ...
Phase II Trial of Irinotecan in Children With Relapsed or Refractory Rhabdomyosarcoma: A Joint Study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group ...
Attitudes and Practices Among Pediatric Oncologists Regarding End-of-Life Care: Results of the 1998 American Society of Clinical Oncology Survey PURPOSE: To investigate the antitumor activity and ...
Survivors of rhabdomyosarcoma may be at higher risk for poorer psychological outcomes, that radiation therapy and smoking may worsen. Survivors of rhabdomyosarcoma may be at an increased risk for poor ...
Rhabdomyosarcoma is the most frequent cancer affecting soft tissues in children, and existing therapies often fail to stop relapse or prolong survival. Researchers in Germany and the U.K. have ...
Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. While multimodal therapies have improved outcomes for low- and intermediate-risk ...
A young boy from Bexhill who was diagnosed with a rare and aggressive form of cancer has been celebrated for his bravery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results